Author:
Brunetti Marta,Andersen Kristin,Spetalen Signe,Lenartova Andrea,Osnes Liv Toril Nygård,Vålerhaugen Helen,Heim Sverre,Micci Francesca
Abstract
IntroductionAlterations of the NUP214 gene (9q34) are recurrent in acute leukemias. Rearrangements of chromosomal band 9q34 targeting this locus can be karyotypically distinct, for example t(6;9)(p22;q34)/DEK::NUP214, or cryptic, in which case no visible change of 9q34 is seen by chromosome banding.MethodsWe examined 9 cases of acute leukemia with NUP214 rearrangement by array Comparative Genomic Hybridization (aCGH), reverse-transcription polymerase chain reaction (RT-PCR), and cycle sequencing/Sanger sequencing to detect which fusion genes had been generated.ResultsThe chimeras DEK::NUP214, SET::NUP214, and NUP214::ABL1 were found, only the first of which can be readily detected by karyotyping.DiscussionThe identification of a specific NUP214 rearrangement is fundamental in the management of these patients, i.e., AMLs with DEK::NUP214 are classified as an adverse risk group and might be considered for allogenic transplant. Genome- and/or transcriptome-based next generation sequencing (NGS) techniques can be used to screen for these fusions, but we hereby present an alternative, step-wise procedure to detect these rearrangements.
Reference41 articles.
1. NUP214 in leukemia: it’s more than transport;Mendes;Cells,2019
2. ‘Acute leukemia’;Rose-Inman;Hematology/oncology Clinics North America,2017
3. Management of acute myeloid leukemia: current treatment options and future perspectives;Fleischmann;Cancers (Basel),2021
4. ‘Basic techniques for the preparation and analysis of’;Czepulkowski;Hum cytogenetics: Malignancy acquired abnormalities,1992